CA2015066A1 - Process for the preparation of quinazoline derivatives - Google Patents

Process for the preparation of quinazoline derivatives

Info

Publication number
CA2015066A1
CA2015066A1 CA2015066A CA2015066A CA2015066A1 CA 2015066 A1 CA2015066 A1 CA 2015066A1 CA 2015066 A CA2015066 A CA 2015066A CA 2015066 A CA2015066 A CA 2015066A CA 2015066 A1 CA2015066 A1 CA 2015066A1
Authority
CA
Canada
Prior art keywords
preparation
quinazoline derivatives
quinazoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2015066A
Other languages
English (en)
Inventor
Jozef Reiter
Laszlo Pongo
Frigyes Gorgenyi
Marton Fekete
Margit Csorgo
Ilona Sztuhar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU193189A external-priority patent/HU203342B/hu
Priority claimed from HU193089A external-priority patent/HU203333B/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CA2015066A1 publication Critical patent/CA2015066A1/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2015066A 1989-04-21 1990-04-20 Process for the preparation of quinazoline derivatives Pending CA2015066A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU193189A HU203342B (en) 1989-04-21 1989-04-21 Process for producing quinazoline deivatives
HU193089A HU203333B (en) 1989-04-21 1989-04-21 Process for producing n-cyano-carboxamidine derivatives

Publications (1)

Publication Number Publication Date
CA2015066A1 true CA2015066A1 (en) 1990-10-21

Family

ID=26317437

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002028953A Abandoned CA2028953A1 (en) 1989-04-21 1990-04-20 Process for the preparation of quinazoline derivatives
CA2015066A Pending CA2015066A1 (en) 1989-04-21 1990-04-20 Process for the preparation of quinazoline derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002028953A Abandoned CA2028953A1 (en) 1989-04-21 1990-04-20 Process for the preparation of quinazoline derivatives

Country Status (16)

Country Link
JP (1) JPH02292282A (xx)
KR (1) KR900016194A (xx)
AT (1) AT398075B (xx)
BG (1) BG91821A (xx)
CA (2) CA2028953A1 (xx)
CH (1) CH681300A5 (xx)
DK (1) DK99090A (xx)
ES (1) ES2019826A6 (xx)
FI (1) FI902002A0 (xx)
GB (1) GB2231571B (xx)
GR (1) GR900100294A (xx)
IT (1) IT1241128B (xx)
PL (1) PL162976B1 (xx)
RU (1) RU1838309C (xx)
SE (1) SE9001402L (xx)
YU (1) YU70890A (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005628A1 (en) 1992-08-31 1994-03-17 Acic (Canada) Inc. Synthesis of 2-substituted quinazoline compounds (such as terazosin) and meobentine and bethanidine and intermediates therefor

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2096518B1 (es) * 1994-03-28 1997-12-01 Grupo Farmaceutico Almirall S Nuevas anilinas.
WO2008015525A2 (en) * 2006-07-31 2008-02-07 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of alfuzosin hydrochloride
WO2008152514A2 (en) 2007-05-04 2008-12-18 Actavis Group Ptc Ehf Process for the preparation of alfuzosin and salts thereof
KR20100044239A (ko) 2007-08-02 2010-04-29 시플라 리미티드 알푸조신 염산염의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044135A (en) * 1975-10-14 1977-08-23 Abbott Laboratories Antihypertensive agents
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4138561A (en) * 1977-09-30 1979-02-06 Bristol-Myers Company Cyanocarboxamidines and quinazoline process
FI56836C (fi) * 1977-10-25 1980-04-10 Fermion Oy 4-substituerade piperazin-1-(n-aryl-n'-cyano)-karboximidamider som aer mellanprodukter vid framstaellningen av farmakologiskt vaerdefulla 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner
FI57751C (fi) * 1977-10-25 1980-10-10 Fermion Oy Foerfarande foer framstaellning av 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner med blodtryckssaenkande verkan
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
FI59800C (fi) * 1979-01-10 1981-10-12 Fermion Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(furo-2-yl)-piperazin-1-yl)-kinazolin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
ATE32074T1 (de) * 1983-11-22 1988-02-15 Heumann Ludwig & Co Gmbh Verfahren zur herstellung von 4-amino-6,7dimethoxy-2-(4-(furo-2-yl)-piperazin-1-yl)chinazolin und dessen physiologisch annehmbarer salze.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005628A1 (en) 1992-08-31 1994-03-17 Acic (Canada) Inc. Synthesis of 2-substituted quinazoline compounds (such as terazosin) and meobentine and bethanidine and intermediates therefor

Also Published As

Publication number Publication date
DK99090D0 (da) 1990-04-20
ES2019826A6 (es) 1991-07-01
BG91821A (bg) 1993-12-24
ATA93190A (de) 1994-01-15
KR900016194A (ko) 1990-11-12
IT9020092A0 (it) 1990-04-20
SE9001402L (sv) 1990-10-22
FI902002A0 (fi) 1990-04-20
GB2231571B (en) 1992-09-16
PL162976B1 (pl) 1994-01-31
JPH02292282A (ja) 1990-12-03
IT1241128B (it) 1993-12-29
GB9008941D0 (en) 1990-06-20
GR900100294A (el) 1991-09-27
GB2231571A (en) 1990-11-21
DK99090A (da) 1990-10-22
YU70890A (en) 1992-05-28
IT9020092A1 (it) 1991-10-20
AT398075B (de) 1994-09-26
PL284860A1 (en) 1991-03-11
CH681300A5 (xx) 1993-02-26
CA2028953A1 (en) 1990-10-22
RU1838309C (ru) 1993-08-30
SE9001402D0 (sv) 1990-04-20

Similar Documents

Publication Publication Date Title
HU895305D0 (en) Process for the preparation of piperidinyl-benzimidazole derivatives
EP0428003A3 (en) Process for the preparation of polyetherglycols
HU895410D0 (en) Process for the preparation of quinolyl-oxazol-2-on derivatives
HU902995D0 (en) Process for the preparation of oxophthalazinyl-acetic acid derivatives
EP0425930A3 (en) Process for the preparation of symmetrical diarylacetylenes
HU901554D0 (en) Process for the preparation of quinoline derivatives
GB2231571B (en) Process for the preparation of quinazoline derivatives
ZA902149B (en) Process for the preparation of o-carboxypyridyl-and o-carboxyquinolylimidazolinones
HU895262D0 (en) Improved process for the preparation of phenfluramine
BG51043A3 (en) Process for the preparation of triazolo derivatives
HU901603D0 (en) Process for the preparation of fluoro-phenols
IL93596A0 (en) Process for the preparation of n-allylmetatrifluoromethyl-aniline
EP0415189A3 (en) Process for the preparation of aminbenzylalcohol
IL95496A0 (en) Process for the preparation of fluoropyridines
EP0412361A3 (en) Process for the preparation of 4-methylentetrahydropyran
EP0358088A3 (en) Process for the preparation of 3-aryl isobutanols
HU896030D0 (en) Process for the preparation of quinazolinone derivatives
GB2236535B (en) Process for the preparation of nu-substituted nitro-p-phenylenediamines
EP0437820A3 (en) Process for the preparation of glycosyl-anthracyclinones
SG43813A1 (en) Process for the preparation of aminotriazine derivatives
ZA894833B (en) Process for the preparation of homonojirimycin derivatives
EP0408881A3 (en) Process for the enantioselective preparation of gamma-keto-delta-amino-acid derivatives
EP0415166A3 (en) Process for the preparation of cyanohydantoines
HU895426D0 (en) Process for the preparation of dihydro-triazolo-tetrazepine derivatives
HU895427D0 (en) Process for the preparation of triazolyl-hydrazone derivatives